Review of delta‐8‐tetrahydrocannabinol (Δ8‐THC): Comparative pharmacology with Δ9‐THC

M Tagen, LE Klumpers - British journal of pharmacology, 2022 - Wiley Online Library
The use of the intoxicating cannabinoid delta‐8‐tetrahydrocannabinol (Δ8‐THC) has grown
rapidly over the last several years. There have been dozens of Δ8‐THC studies dating back …

Cannabis and cannabinoids: kinetics and interactions

BC Foster, H Abramovici, CS Harris - The American journal of medicine, 2019 - Elsevier
Cannabis sativa and related products are widely used, but their potential to cause significant
clinical interactions remains unclear, particularly for cannabinoid-enriched or otherwise …

[HTML][HTML] Oral cannabidiol use in children with autism spectrum disorder to treat related symptoms and co-morbidities

D Barchel, O Stolar, T De-Haan, T Ziv-Baran… - Frontiers in …, 2019 - frontiersin.org
Objective: Children with autism spectrum disorder (ASD) commonly exhibit comorbid
symptoms such as aggression, hyperactivity and anxiety. Several studies are being …

A marijuana-drug interaction primer: precipitants, pharmacology, and pharmacokinetics

EJ Cox, N Maharao, G Patilea-Vrana… - Pharmacology & …, 2019 - Elsevier
Abstract In the United States, the evolving landscape of state-legal marijuana use for
recreational and/or medical purposes has given rise to flourishing markets for marijuana and …

Microglial cell hyper-ramification and neuronal dendritic spine loss in the hippocampus and medial prefrontal cortex in a mouse model of PTSD

KL Smith, MS Kassem, DJ Clarke… - Brain, behavior, and …, 2019 - Elsevier
Few animal models exist that successfully reproduce several core associative and non-
associative behaviours relevant to post-traumatic stress disorder (PTSD), such as long …

The role of brain microvascular endothelial cell and blood-brain barrier dysfunction in schizophrenia

S Pong, R Karmacharya, M Sofman, JR Bishop… - Complex …, 2020 - karger.com
Background: Despite decades of research, little clarity exists regarding pathogenic
mechanisms related to schizophrenia. Investigations on the disease biology of …

[HTML][HTML] Potential adverse drug events with tetrahydrocannabinol (THC) due to drug–drug interactions

JD Brown - Journal of clinical medicine, 2020 - mdpi.com
Tetrahydrocannabinol (THC) is the primary psychoactive ingredient in cannabis. While the
safety of THC and cannabis has been extrapolated from millennia of recreational use …

[HTML][HTML] Herb-anticancer drug interactions in real life based on VigiBase, the WHO global database

S Pochet, AS Lechon, C Lescrainier, C De Vriese… - Scientific reports, 2022 - nature.com
Cancer patients could combine herbal treatments with their chemotherapy. We consulted
VigiBase, a WHO database of individual case safety reports (ICSRs) which archives reports …

Marijuana and the pediatric population

S Dharmapuri, K Miller, JD Klein - Pediatrics, 2020 - publications.aap.org
Cannabinoids, the psychoactive compounds in marijuana, are one of the most commonly
used substances in the United States. In this review, we summarize the impact of marijuana …

A systematic review of phytocannabinoid exposure on the endocannabinoid system: Implications for psychosis

MR Jacobson, JJ Watts, I Boileau, J Tong… - European …, 2019 - Elsevier
Cannabis, the most widely used illicit drug worldwide, produces psychoactive effects
through its component cannabinoids, which act on the endocannabinoid system. Research …